Clinical Trials Logo
  1. Home
  2. Anticoagulation
  3. NCT02492828

Adherence of Apixaban and Warfarin in Patients With Arterial Fibrillation in Real-world Setting in Sweden

Anticoagulation Clinical Trial

Official title:
Adherence of Apixaban and Warfarin in Patients With Atrial Fibrillation in Real-world Setting in Sweden

Clinical Trial Summary

This will be a retrospective cohort study using national register linkage data (including prescription, inpatient, mortality, and socioeconomic data). The study period will be from May 29, 2013 to June 30, 2015. Patients will be followed from the start of treatment (index date) until their death, exiting the database, or until the end of the study period (June 30, 2015).

Clinical Trial Description

n/a

Study Design

Observational Model: Cohort, Time Perspective: Retrospective

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02492828
Study type Observational
Source Bristol-Myers Squibb
Contact
Status Completed
Phase N/A
Start date June 2014
Completion date January 2016
View Details
See also
  Status Clinical Trial Phase
Completed NCT02705976 - Prospective Trial of a Validated Algorithm for Warfarin Dosing N/A
Active, not recruiting NCT04139525 - Comparison of Citrate and Heparin Anticoagulation During Hemodialysis With MCO PES-PVP (Theranova) Membrane N/A
Completed NCT01907048 - Patient and Physician Knowledge of Key Safety Messages
Recruiting NCT03419923 - Three Anticoagulation Strategies for Hemodialysis in Patients at Risk of Hemorrhage N/A
Completed NCT03575936 - Enhanced Pharmacist-Managed Anticoagulation Service in a University-based Family Medicine Clinic N/A
Completed NCT02714855 - Apixaban in the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in Real-Life Setting in France N/A
Recruiting NCT01314235 - Influence of Clonidine on Thrombozytes of Blood of Patients Under Anticoagulation Therapy With ASS and Clopidogrel N/A
Withdrawn NCT04059965 - AntiCoagulation Tracking InterVention and Evaluation N/A
Recruiting NCT02987192 - Minimally Invasive Lumbar Aneasthesia Used for Cesarean Section N/A
Completed NCT01477528 - Study of Reduced Anti-coagulation/Anti-platelet Therapy in Patients With the HeartMate II Left Ventricular Assist System (LVAS) (TRACE)
Recruiting NCT04405232 - Coagulopathy in COVID19 - A Multi-Centre Observational Study in UK
Recruiting NCT02761941 - Excessive Warfarin Anticoagulation - Causes and Consequences N/A
Completed NCT02392104 - Prospective Evaluation of an Extended Interval of INR Follow-up in a VA Anticoagulation Service N/A
Completed NCT01884337 - Multi-center Study to Evaluate the Safety of Apixaban (BMS-562247) in Indian Subjects Undergoing Elective Total Knee Replacement or Total Hip Replacement Surgery Phase 4
Recruiting NCT03473132 - Assessment of Coagulation Factor Levels in Left Ventricular Device (LVAD )Patients Following Temporary Warfarin Reversal With Four Factor Prothrombin Complex Concentrate (4F-PCC) Phase 4
Enrolling by invitation NCT05305612 - Optimal PeriproCeduraL AnticOagulation in Structural Transseptal Interventions Phase 4
Completed NCT03662594 - Growth of High-Quality Oxides on The Inner Surface of ECMO Circuit by ALD to Reduce Thrombus Formation N/A
Active, not recruiting NCT03910933 - Electronic KIDCLOT Interactive Thrombosis/Thrombophilia Education; A Quality Assurance Initiative
Completed NCT03684395 - Accessibility to New Drugs Versus SOC in Sweden
Completed NCT01124058 - Evaluation of Maintenance Dosing vs Loading Dosing Upon Restarting Warfarin Therapy: A Prospective Randomized Trial Phase 1